CS363291A3 - Process for preparing a pharmaceutical in the form of solid capsules - Google Patents

Process for preparing a pharmaceutical in the form of solid capsules Download PDF

Info

Publication number
CS363291A3
CS363291A3 CS913632A CS363291A CS363291A3 CS 363291 A3 CS363291 A3 CS 363291A3 CS 913632 A CS913632 A CS 913632A CS 363291 A CS363291 A CS 363291A CS 363291 A3 CS363291 A3 CS 363291A3
Authority
CS
Czechoslovakia
Prior art keywords
nifedipine
polyethylene glycol
weight
capsules
polyvinylpyrrolidone
Prior art date
Application number
CS913632A
Other languages
Czech (cs)
English (en)
Inventor
Minoru Aoki
Minoru Nakada
Yuichi Yazawa
Genichi Izu
Takashi Terada
Original Assignee
Nippon Kayaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Kk filed Critical Nippon Kayaku Kk
Publication of CS363291A3 publication Critical patent/CS363291A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS913632A 1990-11-29 1991-11-29 Process for preparing a pharmaceutical in the form of solid capsules CS363291A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32544390 1990-11-29

Publications (1)

Publication Number Publication Date
CS363291A3 true CS363291A3 (en) 1992-06-17

Family

ID=18176920

Family Applications (1)

Application Number Title Priority Date Filing Date
CS913632A CS363291A3 (en) 1990-11-29 1991-11-29 Process for preparing a pharmaceutical in the form of solid capsules

Country Status (8)

Country Link
EP (1) EP0488181A1 (hu)
JP (1) JPH0517356A (hu)
KR (1) KR920009395A (hu)
CN (1) CN1061905A (hu)
AU (1) AU8823391A (hu)
CA (1) CA2056032A1 (hu)
CS (1) CS363291A3 (hu)
HU (1) HU206622B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100578669B1 (ko) * 1997-05-29 2006-12-07 동아제약주식회사 우르소데옥시콜린산을함유하는투명연질캅셀
WO2001060353A1 (fr) * 2000-02-21 2001-08-23 Fujisawa Pharmaceutical Co., Ltd. Preparation liquide a absorbabilite amelioree
WO2002087543A1 (en) * 2001-05-01 2002-11-07 Biozone Laboratories, Inc. Sustained release formulations for nifedipine, dextromethorphan, and danazol
DE102008059201A1 (de) 2008-11-27 2010-06-02 GÖPFERICH, Achim, Prof. Dr. In situ präzipitierende Arzneistofflösungen
DE102021003906B4 (de) 2021-07-30 2023-03-30 Mirco Bienhaus Verfahren und Vorrichtungen zur Herstellung fester oder halbfester Arzneiformen mit einem mehrschichtigen Aufbau

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU432703A3 (hu) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules

Also Published As

Publication number Publication date
AU8823391A (en) 1992-06-04
HUT59601A (en) 1992-06-29
EP0488181A1 (en) 1992-06-03
HU206622B (en) 1992-12-28
CN1061905A (zh) 1992-06-17
CA2056032A1 (en) 1992-05-30
HU913711D0 (en) 1992-02-28
KR920009395A (ko) 1992-06-25
JPH0517356A (ja) 1993-01-26

Similar Documents

Publication Publication Date Title
DK165902B (da) Etoposid-praeparat
US5244881A (en) Compositions based on imipyramine
CS363291A3 (en) Process for preparing a pharmaceutical in the form of solid capsules
JP2010280739A (ja) ビノレルビンを含むソフトカプセルのための経口製薬組成物及び治療方法
US4902513A (en) Oral sustained release medicament
CN114652684B (zh) 固体药物组合物及其制法
Gowthamarajan et al. Formulation and dissolution properties of meloxicam solid dispersion incorporated suppositories
FI63670B (fi) Foerfarande foer framstaellning av digoxin innehaollande doseringsenheter
RU2257885C2 (ru) Устойчивое лекарственное средство и способ его изготовления
ES2224175T3 (es) Granulos farmaceuticos.
ES2967362T3 (es) Método para suprimir el amargor de un derivado de quinolina
DK164019B (da) Stabiliseret flydende laegemiddelpraeparat indeholdende ioniske laegemidler med protraheret virkning samt fremgangsmaade til fremstilling deraf
Rahul et al. A review on immediate release drug delivery systems
CZ277775B6 (en) Process for preparing ethopside agent
US4948591A (en) Soft capsular preparation of sodium picosulfate
Pramar et al. Development of a stable oral liquid dosage form of spironolactone
US5403594A (en) Oral spiramycin formulations and method for preparing same
US3639565A (en) Gastric-resistant tablets coated with erythrosine and hydroxypropylethylcellulose
JPS58105913A (ja) ニフエジピン軟カプセル剤
CN116019815B (zh) 一种头孢托仑匹酯药物组合物及其制备方法
JPS62289530A (ja) 溶解遅延性のゼラチン製剤組成物
JPH03255024A (ja) 口中易溶軟カプセル剤
JPS61207329A (ja) 親水性物質を充てんした軟カプセル剤
ITMI972893A1 (it) Procedimento per la preparazione di un composto in granuli ad azione prolungata che contiene 4-nitro-2 fenossimetansolfonanilide
CA2388431C (en) Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment